LoginRegister
    OPOS, Fullpower enter partnership to create-The First 24/7 Opioid Compliance SolutionOPOS, Fullpower enter partnership to create-The First 24/7 Opioid Compliance Solution
    Patent Infringement: Case against Natco Pharma in US court over generic version of cancer drug LonsurfPatent Infringement: Case against Natco Pharma in US court over generic version of cancer drug...
    Dr Reddys secures shareholders nod for amalgamation of Dr Reddys Holdings into companyDr Reddys secures shareholders nod for amalgamation of Dr Reddys Holdings into company
    Novo Nordisk to offer free insulin to US patientsNovo Nordisk to offer free insulin to US patients
    Merck, Novartis, Allergan to raise US drug prices for 100 drugsMerck, Novartis, Allergan to raise US drug prices for 100 drugs
    Sonoco acquires healthcare packaging, medical device thermoformer-TEQ for USD 187 millionSonoco acquires healthcare packaging, medical device thermoformer-TEQ for USD 187 million
    Karnataka: Around 2000 Govt Pharmacists launch protest, threaten indefinite strikeKarnataka: Around 2000 Govt Pharmacists launch protest, threaten indefinite strike
    Novo Nordisk names Vikrant Shrotriya as Managing Director for India businessNovo Nordisk names Vikrant Shrotriya as Managing Director for India business
    Aurobindo Pharma recalls Mirtazapine tablets in US over labelling errorAurobindo Pharma recalls Mirtazapine tablets in US over labelling error
    Pacific Biosciences, Illumina cancel USD 1.2 billion dealPacific Biosciences, Illumina cancel USD 1.2 billion deal
    MSN Labs subsidiary Novadoz Pharma gets USFDA nod for generic UloricMSN Labs subsidiary Novadoz Pharma gets USFDA nod for generic Uloric
    11 Drugs Controller Officers appointed in Punjab; Details11 Drugs Controller Officers appointed in Punjab; Details
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X